0 Items
Select Page

Secondary Reagents

Secondary antibodies and related reagents are vital tools for immunological assays. We offer a range of high quality, affinity purified secondary antibodies that can be used in a variety of assays in conjunction with our range of primary antibodies.

Secondary reagents

The secondary reagents supplied by the Native Antigen Company include a range of highly purified goat polyclonal antibodies against human, mouse or sheep IgG. These antibodies are available unconjugated and are also available conjugated to widely used enzymes, horseradish peroxidase (HRP), alkaline phosphatase (AP) or to the popular fluorochrome fluorescein isothiocyanate (FITC). Additional secondary reagents include streptavidin conjugates, which are suitable for use in a wide range of applications to detect biotin-conjugated detection reagents. All the reagents supplied are suitable for immunoassay research and development.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Challenges to Effective Yellow Fever Diagnostics

Yellow fever is a haemorrhagic viral disease, transmitted by infected mosquitos in Africa and South America. While an effective vaccine is available, inadequate vaccination of endemic areas has made diagnostics a necessity to controlling ongoing outbreaks. However,...

Five Methods You Can Use to Overcome Zika-Dengue Cross-Reactivity

Cross-reactivity between the Zika and Dengue viruses in serological assays is one of the biggest challenges faced by the epidemiologists, academics and pharmaceutical companies trying to control the Zika epidemic, as it brings the quality and reliability of diagnostic...

Why Zika virus’s cross-reactivity with Dengue might be hampering your research

Given the impact of Zika, it’s no surprise that a global contingent of epidemiologists, academic researchers, and pharmaceutical companies are striving to develop effective disease control measures and treatments. One challenge currently hindering the...

How The Native Antigen Company responds to the WHO list of priority infectious diseases

In 2015, a broad group of public health and science experts gathered in Geneva to discuss emerging infectious diseases that are likely to cause future severe epidemics and public health emergencies. Organised by the World Health Organization (WHO), their aim was to...

Native Antigen release a panel of serotype specific monoclonal antibodies

  There are four distinct serotypes of Dengue Virus circulating around the world, causing Dengue fever infection which is the most important worldwide arboviral disease. There are nearly 400 million cases of Dengue annually, and around 25% present with so called...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

9 + 12 =

Live Customer Feedback